Abstract submissions are now closed.






Abstracts will be reviewed and selected on the basis of their scientific merit and content quality. Submitted abstracts meeting the eligibility requirements will be considered for poster presentations on September 15 to 17, 2022. The top abstracts will also be awarded and presented orally in the conference general session.

We invite you to participate by submitting a 250 word abstract, which should describe work with relevance to Breast Cancer Coordinated Care.

All material presented in the abstract must be current, relevant and free from ethical bias. Company logos of the supporting company are prohibited on any part of the presentation. All abstracts received will be considered to be presented as POSTER ABSTRACTS during the conference.

Submission Deadline: Abstracts must be submitted by August 5, 2022. 

Abstract Acceptance

  • Acceptance notification will be sent via email by August 15, 2022
  • Abstracts are selected on the basis of scientific merit.
  • Expenses associated with the presentation of an abstract are the responsibility of the presenter.
  • At least one presenting/submitting author per abstract must be registered.

Abstract Presentation

All accepted abstracts will be poster presentations. Poster size is 4 feet tall x 3.5 feet wide.

Please note the submitting author will receive all correspondence about the abstract so we advise that the submitting author is who you would prefer to receive all communication.

You may submit more than 1 abstract. However, presenters that are accepted for oral presentation will be permitted to give only 1 oral presentation.  Additional accepted abstracts will therefore be poster only.